PE20030815A1 - Derivados de drechsleranol, procedimiento para su preparacion y su utilizacion - Google Patents

Derivados de drechsleranol, procedimiento para su preparacion y su utilizacion

Info

Publication number
PE20030815A1
PE20030815A1 PE2003000091A PE2003000091A PE20030815A1 PE 20030815 A1 PE20030815 A1 PE 20030815A1 PE 2003000091 A PE2003000091 A PE 2003000091A PE 2003000091 A PE2003000091 A PE 2003000091A PE 20030815 A1 PE20030815 A1 PE 20030815A1
Authority
PE
Peru
Prior art keywords
alkenyl
alkyl
refers
formula
derivatives
Prior art date
Application number
PE2003000091A
Other languages
English (en)
Inventor
Claudia Eder
Luigi Toti
Michael Kurz
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PE20030815A1 publication Critical patent/PE20030815A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Abstract

SE REFIERE A DERIVADOS DE DRECHSLERANOLES DE FORMULA I DONDE R ES H, -(CH(OR2))5-CH2-OR2; R1 Y R2 SON H, ALQUILO, ALQUENILO, ALQUINILO, ARILO; OH, =O, O-ALQUILO, O-ALQUENILO, NH-ALQUILO, NH-ALQUENILO, NH2; HALOGENO. SON COMPUESTOS PREFERIDOS DE FORMULA II, III. TAMBIEN SE REFIERE A COMPUESTOS DE FORMULA EMPIRICA C26H24O9; C20H12O3 CARACTERIZADOS POR SU ESPECTRO 1H-RMN. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION Y A LA CEPA DRECHSLERA AUSTRALIENSIS ST003660, DSM 14093; ST 004112, DSM 14524. EL COMPUESTO ES INHIBIDOR DE QUINASAS N-TERMINALES C-JUN JNK-3, CK-1 Y PUEDE SER UTIL PARA EL TRATAMIENTO DE DEPRESION, TRASTORNOS DE SUENO, TRASTORNOS AFECTIVOS CONDICIONADOS ESTACIONALMENTE; ENFERMEDADES PSIQUICAS, ALZHEIMER, NEUROPATIAS DEGENERATIVAS
PE2003000091A 2002-01-29 2003-01-29 Derivados de drechsleranol, procedimiento para su preparacion y su utilizacion PE20030815A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203557A DE10203557A1 (de) 2002-01-29 2002-01-29 Drechsleranol-Derivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
PE20030815A1 true PE20030815A1 (es) 2003-10-10

Family

ID=7713383

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000091A PE20030815A1 (es) 2002-01-29 2003-01-29 Derivados de drechsleranol, procedimiento para su preparacion y su utilizacion

Country Status (12)

Country Link
EP (1) EP1472240B1 (es)
JP (1) JP4436134B2 (es)
AR (1) AR038233A1 (es)
AT (1) ATE466848T1 (es)
AU (1) AU2003201963B2 (es)
BR (1) BR0307199A (es)
CA (1) CA2473988C (es)
DE (2) DE10203557A1 (es)
IL (1) IL163166A (es)
MX (1) MXPA04006358A (es)
PE (1) PE20030815A1 (es)
WO (1) WO2003064405A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105339362B (zh) * 2013-06-26 2017-09-01 Dic株式会社 含酚性羟基化合物、酚醛树脂、固化性组合物、其固化物、半导体密封材料、及印刷电路基板

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3068706B2 (ja) * 1992-02-26 2000-07-24 塩野義製薬株式会社 アルド−ス還元酵素阻害物質

Also Published As

Publication number Publication date
AR038233A1 (es) 2005-01-05
DE10203557A1 (de) 2003-08-07
WO2003064405A1 (de) 2003-08-07
IL163166A (en) 2008-08-07
AU2003201963B2 (en) 2008-06-05
MXPA04006358A (es) 2004-10-04
DE50312692D1 (de) 2010-06-17
CA2473988A1 (en) 2003-08-07
BR0307199A (pt) 2004-11-03
CA2473988C (en) 2011-05-03
ATE466848T1 (de) 2010-05-15
JP4436134B2 (ja) 2010-03-24
EP1472240A1 (de) 2004-11-03
JP2006503797A (ja) 2006-02-02
EP1472240B1 (de) 2010-05-05

Similar Documents

Publication Publication Date Title
UY28280A1 (es) 2- hidroxi - 3- diaminoalcanos de benzamida
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
HN2002000067A (es) Inhibidores de la rho - quinasa.
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
PE20041000A1 (es) Pirazolopirimidinas como inhibidores de la quinasa dependientes de ciclina
PE20041076A1 (es) Nuevas pirazolopirimidinas como inhibidores de la quinasa dependientes de ciclina
PE20060504A1 (es) Derivados de pirimidina en el tratamiento de cancer
ATE437872T1 (de) Proteinkinaseinhibitoren
PE28797A1 (es) Derivados del acido arilsulfonilamino hidroxamico
HK1074794A1 (en) The use of substituted cyanopyrrolidines for treating hyperlipidemia
YU95303A (sh) Ligandi 5-ht receptora i njihova upotreba
UY27234A1 (es) Inhibidores novedosos de tirosina cinasa
AR028824A1 (es) Compuestos antagonistas npy-5 y su uso en la manufactura de medicamentos.
UY28101A1 (es) Ureas substituidas y carbamatos útiles para el tratamiento de la enfermedad de alzheimer
CL2003002665A1 (es) COMPUESTOS DERIVADOS DE ACIDOS CARBOXILICOS, SUS SALES; PROCEDIMIENTO DE PREPARACION; COMPOSICION FARMACEUTICA, Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES DONDE ES NECESARIO UN INHIBIDORE DEL FACTOR Xa Y /O UN INHIBIDOR DE SERINA PROTEASA.
TNSN04165A1 (en) Substituted hydroxyethylamines
HK1079526A1 (en) A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin
BR0315777A (pt) Uso de derivados de piperazina como antagonistas ccr1
PE20060575A1 (es) Derivados de amino-tropano como agonistas de los receptores de melanocortinas
SE0104331D0 (sv) Novel compounds
YU75603A (sh) Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja
BG108180A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
DE60220385D1 (de) Benzimidazole zur behandlung sexueller fehlfunktionen
ATE417856T1 (de) Motilidverbindungen
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización

Legal Events

Date Code Title Description
FA Abandonment or withdrawal